”Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always seek the advice of your physician or qualified health provider with any questions you may have regarding a medical condition.
Checking your blood sugar used to mean pricking your finger several times a day. But continuous glucose monitoring (CGM) has transformed how people with diabetes manage their condition.
The 2025 ADA guidelines now recommend CGM for all patients with type 1 diabetes and suggest it for many with type 2 diabetes.
So which method is right for you? Let's compare fingerstick testing versus CGM.
The Two Methods Explained
Fingerstick Glucometers (BGM)
What they are: Small devices that measure glucose in a drop of blood from a finger prick.
| Component | Description |
|---|---|
| Meter | The device that reads the test strip |
| Test strip | Chemically treated strip that reacts to blood glucose |
| Lancet device | Spring-loaded tool to prick finger |
| Lancet | Small needle that creates the puncture |
Process: Prick finger → Apply blood to test strip → Meter reads glucose in 5-10 seconds
Continuous Glucose Monitors (CGM)
What they are: Wearable sensors that measure glucose in interstitial fluid (fluid between cells) every 1-5 minutes.
| Component | Description |
|---|---|
| Sensor | Inserted under skin, lasts 7-14 days |
| Transmitter | Sends data from sensor to receiver/phone |
| Receiver/display | Device or smartphone that shows glucose |
Process: Insert sensor → Auto-measures glucose every 1-5 minutes → Data transmitted to display device
Accuracy Comparison
How They Compare to Laboratory Values
| Method | MARD (Mean Absolute Relative Difference) |
|---|---|
| Modern CGM | 9-10% |
| Fingerstick meters | 5-10% |
MARD measures how close the device matches lab reference values. Lower is better.
Important Considerations
| Factor | Fingerstick | CGM |
|---|---|---|
| Measures | Blood glucose | Interstitial glucose |
| Lag time | None | 5-15 minute lag behind blood |
| Accuracy | Very accurate | Generally accurate |
| Calibration | Factory calibrated | Some require calibration, others don't |
Key point: Interstitial glucose lags behind blood glucose by 5-15 minutes. This means CGM readings may differ from fingerstick during rapid glucose changes.
Advantages and Disadvantages
Fingerstick Glucometers
| Advantages | Disadvantages |
|---|---|
| No lag time | Measures blood directly |
| Inexpensive | Meters often free; strips cost |
| No wearable | Nothing attached to body |
| No insertion | No sensor under skin |
| Immediate calibration | Factory calibrated |
| Simplicity | Easy to use |
Continuous Glucose Monitors
| Advantages | Disadvantages |
|---|---|
| Continuous data | 288 readings/day |
| Trend information | See direction/rate of change |
| Alarms | Hypo/hyperglycemia alerts |
| No fingersticks | Some require none, some fewer |
| Pattern insights | See food/activity effects |
| Remote monitoring | Share data with caregivers |
What CGM Measures Beyond Fingersticks
Time in Range (TIR)
The percentage of time glucose is in target range (70-180 mg/dL):
| TIR | A1C Equivalent | Clinical Meaning |
|---|---|---|
| > 70% | ~7.0% | Target for most adults |
| > 50% | ~8.0% | Target for older adults/high risk |
| <50% | > 8.0% | Suboptimal control |
Why TIR matters: TIR correlates with A1C but provides additional information about daily patterns and hypoglycemia risk.
Time Below Range (TBR)
The percentage of time glucose is low:
| Level | Threshold | Target |
|---|---|---|
| Level 1 | ＜ 70 mg/dL | ＜ 4% of time |
| Level 2 | ＜ 54 mg/dL | ＜ 1% of time |
Time Above Range (TAR)
The percentage of time glucose is elevated (> 180 mg/dL):
| Level | Target |
|---|---|
| TAR | ＜ 25% of time |
| Very high TAR (> 250 mg/dL) | Minimize |
Glucose Variability
CGM shows how much glucose fluctuates:
- Standard deviation (SD) of glucose
- Coefficient of variation (CV) = SD/mean glucose × 100
- Target CV: ＜ 36% for most patients
High variability = more peaks and valleys, even if A1C is at target.
Available CGM Systems
Real-Time CGM (rtCGM)
| System | Features | Calibration | Sensor Life |
|---|---|---|---|
| Dexcom G7 | No fingersticks for calibration | None | 10 days |
| Dexcom G6 | Optional calibration | Optional | 10 days |
| Abbott FreeStyle Libre 3 | Optional alarms | Optional | 15 days |
| Medtronic Guardian 4 | Predictive low alerts | Required | 7 days |
Intermittently Scanned CGM (isCGM)
| System | Features | Calibration | Sensor Life |
|---|---|---|---|
| FreeStyle Libre 2 | Alarms optional | Optional | 14 days |
| FreeStyle Libre 3 | Real-time alarms | Optional | 15 days |
Factory-Calibrated vs. Requires Calibration
| Type | Example | Fingersticks Needed |
|---|---|---|
| Factory calibrated | Dexcom G7, Libre 3 | Optional for confirmation |
| Requires calibration | Dexcom G6 (optional), Guardian 4 | 2x daily |
Cost Considerations
Fingerstick Testing Costs
| Item | Approximate Cost (retail) |
|---|---|
| Meter | Free (with purchase of strips) |
| Test strips | $0.50-$1.50 per strip |
| Lancets | $0.05-$0.15 each |
| 4x daily testing | $60-$180/month |
CGM Costs
| System | Monthly Cost (retail) |
|---|---|
| Dexcom G7 | $300-$400/month |
| FreeStyle Libre 3 | $120-$200/month |
| Guardian 4 | $250-$350/month |
Insurance Coverage
| Coverage Type | What's Typically Covered |
|---|---|
| Medicare | CGM for all diabetes on insulin; some state coverage for others |
| Private insurance | Varies; often covers for type 1, some type 2 on insulin |
| Medicaid | Varies by state |
Cost-saving options:
- Manufacturer savings programs
- Medicare DME coverage for qualifying patients
- State-specific coverage
Who Should Use Which Method?
2025 ADA Recommendations
| Patient Type | Recommendation |
|---|---|
| Type 1 diabetes | CGM strongly recommended for all |
| Type 2 diabetes on insulin | CGM recommended |
| Type 2 diabetes not on insulin | CGM should be considered |
| Pregnancy (with diabetes) | CGM recommended |
| Hypoglycemia unawareness | CGM recommended |
| Cost constraints | BGM may be more practical |
When Fingerstick May Be Preferred
- Cannot afford CGM (no insurance coverage)
- Prefers not to wear device
- Diabetes well-controlled with stable routines
- Rare hypoglycemia
- Fingersticks 1-2x/day is sufficient
When CGM Is Clearly Superior
- Type 1 diabetes (strong recommendation)
- Type 2 on basal-bolus insulin
- Hypoglycemia unawareness or frequent hypoglycemia
- Pregnancy with diabetes
- Need for trend information
- A1C doesn't tell the story (wide swings)
- Motivated by data/technology
Making the Most of Each Method
Fingerstick Best Practices
| Best Practice | Why It Matters |
|---|---|
| Wash hands before testing | Residual sugar can affect readings |
| Use side of fingertip | Less painful than pads |
| Rotate sites | Prevents callus buildup |
| Check at consistent times | Identifies patterns |
| Record results | Track trends over time |
| Bring meter to appointments | Review with healthcare provider |
Optimal Testing Times
| When to Test | What It Tells You |
|---|---|
| Fasting (morning) | Baseline insulin effectiveness |
| Before meals | Pre-meal glucose, dosing guide |
| 2 hours post-meal | Effect of meal on glucose |
| Before bed | Safe for sleep |
| 2-3 AM (occasionally) | Nocturnal hypoglycemia |
| When feeling off | Confirm hypo/hyperglycemia |
| Before driving | Safe for driving |
CGM Best Practices
| Best Practice | Why It Matters |
|---|---|
| Calibrate if required | Ensures accuracy |
| Keep sensor in place | Prevents early loss |
| Use trend arrow | Predict where glucose is going |
| Set alarms appropriately | Alerts without alarm fatigue |
| Scan frequently (if isCGM) | Complete data picture |
| Review reports | Identify patterns |
| Share with providers | Data-driven treatment decisions |
The Future of Glucose Monitoring
Emerging Technologies
| Technology | Status | Potential Impact |
|---|---|---|
| Longer-lasting sensors | In development | Fewer sensor changes per year |
| Fully implantable | In clinical trials | 90+ day sensors |
| Non-invasive | In development | No sensor under skin |
| Smartwatch integration | Available | Greater convenience |
| Artificial intelligence | Emerging | Predictive analytics |
Key Takeaways
- CGM provides continuous data; fingerstick provides snapshots
- CGM is recommended for all type 1 diabetes and many type 2 patients
- Fingerstick remains useful for occasional calibration and verification
- CGM reveals patterns missed by fingerstick alone
- Time in Range is the key CGM metric (target > 70%)
- Cost remains a barrier for CGM but coverage is improving
- Both methods have value—the best choice depends on your situation
FAQ Section
Is CGM more accurate than fingerstick?
Modern CGM systems have accuracy similar to fingerstick meters (MARD ~9-10% for both). However, CGM measures interstitial fluid, which lags behind blood glucose by 5-15 minutes. For most clinical decisions, both are sufficiently accurate.
How often should you check your blood sugar with fingersticks?
If you're not using CGM: 2-4 times daily is typical for type 2 diabetes on oral medications; 4-6+ times daily for type 1 or type 2 on insulin. If using CGM: fingersticks are primarily for calibration (if required) and to confirm CGM readings during symptoms or rapidly changing glucose.
What is Time in Range?
Time in Range (TIR) is the percentage of time your glucose is in target range (70-180 mg/dL). It's a key CGM metric that correlates with A1C but provides additional information about glucose variability and hypoglycemia risk. The target is > 70% for most adults.
Can you stop fingersticks with CGM?
Some factory-calibrated CGM systems (Dexcom G7, Libre 3) don't require calibration fingersticks. However, fingersticks may still be useful to confirm CGM readings during symptoms of hypoglycemia or when glucose is changing rapidly. Always have a backup glucose testing method available.
Does Medicare cover CGM?
Medicare covers CGM for all beneficiaries with diabetes who use insulin (some state mandates may cover others). Coverage includes the sensor, transmitter, and receiver. Durable Medical Equipment (DME) suppliers typically provide the CGM. Check with your specific Medicare plan for details.
Sources:
- American Diabetes Association. Standards of Care in Diabetes—2025. Diabetes Care 2025; 48(Suppl 1)
- CGM Information